Triple Helix Discovery Engine
*Driving Forces: Triple Helix _ Translation, Commercialization, Technology Transfer, SBIR/STTR, OTA, NonTraditional / New Business Models
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Sama Therapeutics

Organization & Developments: Sama Therapeutics

Parents

* Agile SaaS platform, iMAGiNE™, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets.
*Neuropsychiatric biomarker platform integrates artificial intelligence analytics, computational neuroscience, transdiagnostic efficacy assessments, and digital twin modelingate clinical trials, improve treatment outcomes, and gain deeper insights into brain health across diverse neurological and psychiatric conditions.
*Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes.